Progenics Pharmaceuticals PGNX and partner Wyeth WYE announced Thursday that both the Food and Drug Administration and the European Medicines Agency have accepted
Progenics Pharmaceuticals PGNX announced on March 6 that it would backtrack and reformulate the oral version opioid bowel dysfunction drug MNTX to make it more
(Reuters) - Shares of Salix Pharmaceuticals Ltd and Progenics Pharmaceuticals tumbled after U.S. health regulators declined to approve wider use of their drug for opioid-induced constipation and...
We are no longer providing equity research on Progenics Pharmaceuticals PGNX . We provide broad coverage of more than 1,700 companies across more than 140 industries, and adjust our coverage as necessary based on client demand and investor interest.
We're dropping coverage of Progenics Pharmaceuticals PGNX to focus our resources elsewhere.
Progenics Pharmaceuticals PGNX announced that it extended its domestic commercialization agreement with former partner Wyeth (now part of Pfizer PFE) by three
Progenics Pharmaceuticals PGNX reported first-quarter earnings that were slightly lower than we expected, but we are holding on to our probability-weighted
We are maintaining our fair value estimate for Progenics PGNX , as no deals have transpired to affect our probability-weighted scenarios for the firm. The firm brought research and development
Progenics Pharmaceuticals PGNX announced Wednesday that it has regained worldwide rights to the Relistor franchise from its partner Wyeth WYE (soon to be acquired
Progenics Pharmaceuticals ' PGNX revenue for the second quarter came in slightly below our expectations, but this doesn't change our long-term outlook. We